Commercial Information Circulars
24-hour hotline : 23 922 922
e-mail address : enquiry@tid.gov.hk
Ref. : EIC 631/2/5/1
29 September 2021
Dear Sirs,
Commercial Information Circular No. 677/2021
The Mainland of China : Public Consultation on "Provisions for Drug Recall (Consultation Draft)"
The National Medical Products Administration (NMPA) is seeking further comments from the public on the "Provisions for Drug Recall (Consultation Draft)". Interested parties can submit their comments to the NMPA by email before 29 October 2021. Please refer to the Appendix (pdf format) for the letter inviting public comments (available in Chinese only).
ENQUIRIES
2.If you have any questions on the content of the document mentioned in this circular, please contact the issuing authority of the Mainland of China direct. For other questions on this circular, please contact Mainland Branch (I) (tel: 2398 5444) of the Department.
Yours faithfully,
(Calvin CHOY)
for Director-General of Trade and Industry
Note: While every effort is made to ensure the accuracy of the above information, the Department cannot guarantee this to be so and will not be held liable for any reliance placed on the same.